Shukra Pharmaceuticals Quarterly Results for Trading Insights
SHUKRAPHAR • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹10 Cr
QMarch 2025
Shukra Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹37 Cr in March 2025 (+0.0% vs March 2025, -51.9% vs March 2024)
- Net Profit of ₹10 Cr in March 2025 (+0.0% vs March 2025, -47.4% vs March 2024)
- EBITDA of ₹17 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 39.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹0.22 in March 2025 (+0.0% vs March 2025)
Shukra Pharmaceuticals Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 40 | 37 | 77 | 60 | 21 | 8.1% | - |
| Net Profit (₹ Cr) | 12 | 10 | 19 | 4 | 1 | - | - |
| EBITDA (₹ Cr) | 17 | 17 | 22 | 7 | 3 | - | - |
| EPS (₹) | 0.90 | 0.22 | 16.93 | 26.21 | 4.79 | - | - |
| Operating Margin (%) | 27.0% | 39.0% | 26.0% | 9.0% | 14.0% | - | - |
Shukra Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Shukra Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Shukra Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Shukra Pharmaceuticals
Additional stock information and data for SHUKRAPHAR
Revenue Trend (₹ Cr)
March 2023
60
March 2024
77
March 2025
37
2026
40
Net Profit Trend (₹ Cr)
March 2023
4
March 2024
19
March 2025
10
2026
12
Operating Margin Trend (%)
March 2023
9.0%
March 2024
26.0%
March 2025
39.0%
2026
27.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Shukra Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1782.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 137.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 4092.2 | 3,219 | 591 | +11.3% | - | 18.4% | 233.3 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1467.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1242.8 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores